Hemp Health Spolka Akcyjna Logo

Hemp Health Spolka Akcyjna

A vertically integrated supplier of medical cannabis raw material for the Polish market.

HMP | WAR

Overview

Corporate Details

ISIN(s):
PLEBCSL00011 (+4 more)
LEI:
259400HT196UIMTSG008
Country:
Poland
Address:
WARSZAWA JANA STYKI 23, 03-928 WARSZAWA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Hemp & Health S.A. is a company operating at the intersection of the hemp and health sectors. The company's 2024-2025 strategy is centered on creating and managing a vertically integrated supply chain for medical marijuana. Its planned operations span from proprietary cultivation, importation, and processing to the final distribution of medical cannabis as a pharmaceutical raw material. The company's primary strategic objective is to establish itself as a leading Polish entity in the medical cannabis market, controlling the entire value chain to ensure quality and supply.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-05-10 10:55
M&A Activity
Rozpoczęcie negocjacji dotyczących nabycia przez Hemp_Health spółki z branży ma…
Polish 1.2 KB
2024-04-30 13:22
Share Issue/Capital Change
Przydział warrantów subskrypcyjnych serii B - Content (PL)
Polish 831 bytes
2024-04-23 20:47
M&A Activity
Zakończenie negocjacji opisanych w raporcie ESPI nr 5/2024 bez uzyskania porozu…
Polish 845 bytes
2024-04-22 12:22
Major Shareholding Notification
zal01_DC.22.04.2024.FormularzA.pdf
Polish 49.4 KB
2024-04-22 12:22
Major Shareholding Notification
Zmiana stanu posiadania - Content (PL)
Polish 562 bytes
2024-04-15 09:35
Legal Proceedings Report
Złożenie wniosku na import surowca farmaceutycznego przez spółkę stowarzyszoną …
Polish 1.4 KB
2024-03-28 08:33
M&A Activity
Zwrot pożyczonych akcji Cannabis Poland S.A. - Content (PL)
Polish 761 bytes
2024-03-20 21:48
Share Issue/Capital Change
Podwyższenie kapitału zakładowego spółki zależnej w wyniku nowej emisji akcji -…
Polish 707 bytes
2024-02-22 11:36
Share Issue/Capital Change
Zawarcie umowy inwestycyjnej w związku z istotnym dokapitalizowaniem spółki Hem…
Polish 2.4 KB
2024-02-21 12:29
M&A Activity
Podpisanie Term Sheet dotyczącego nabycia plantacji marihuany medycznej przez H…
Polish 1.9 KB
2024-02-12 13:16
Regulatory News Service
Podpisanie Term Sheet z portugalskim zakładem farmaceutycznym przez spółkę stow…
Polish 2.3 KB
2024-02-09 11:35
Regulatory News Service
Otrzymanie zezwolenia na prowadzenie obrotu hurtowego środkami odurzającymi ora…
Polish 1.4 KB
2024-01-22 08:42
M&A Activity
Zawarcie listu intencyjnego dotyczącego przeprowadzenia negocjacji dotyczących …
Polish 1.3 KB
2024-01-15 16:20
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Walnym Zgroma…
Polish 934 bytes
2023-12-19 16:35
Proxy Solicitation & Information Statement
zal03_H_H-NWZ-15.01.24-formularz_pelnomocnictwa.pdf
Polish 164.4 KB

Automate Your Workflow. Get a real-time feed of all Hemp Health Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Hemp Health Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Hemp Health Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America
ABEO
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom
ABDX

Talk to a Data Expert

Have a question? We'll get back to you promptly.